OLIGOMETASTATIC DISEASE
Clinical trials for OLIGOMETASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC DISEASE trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to halt spread of prostate cancer
Disease control OngoingThis study tests a treatment plan for men with prostate cancer that has spread to a few other parts of the body (oligometastatic). The treatment combines focused radiation with a hormone therapy (ADT), a drug called abiraterone, and a targeted drug called Lynparza (olaparib). The…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
New combo therapy shows promise for stopping colorectal cancer spread
Disease control OngoingThis study tests whether adding a targeted treatment (local ablative therapy) to standard chemotherapy can help people with colorectal cancer that has spread to a few spots live longer without the cancer growing. About 6 participants whose cancer responded to initial chemotherapy…
Matched conditions: OLIGOMETASTATIC DISEASE
Phase: NA • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control
Last updated May 26, 2026 03:04 UTC